A Clinical Study to Evaluate LVIVO-TaVec200 for the Treatment of Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07294625 · RECRUITING
Trial details
- NCT number
- NCT07294625
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-10
- Primary completion
- 2027-03-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.